Quetiapine Fumarate Tablet
Product Images NDC 71335-2428

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 71335-2428). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (E6dd3e1f 31d1 4d58 A717 D0bb4a4b8b6d 01)

Molecular Structure (E6dd3e1f 31d1 4d58 A717 D0bb4a4b8b6d 01)
Chemical structure of quetiapine fumarate, showing the quetiapine cationic moiety with aromatic rings and a sulfur atom, and the fumarate anion with carboxylate groups.*
FDA Label Image

Figure 1 (E6dd3e1f 31d1 4d58 A717 D0bb4a4b8b6d 02)

Figure 1 (E6dd3e1f 31d1 4d58 A717 D0bb4a4b8b6d 02)
This is a Kaplan-Meier survival curve showing the proportion of patients with relapse over 100 weeks. The chart compares two groups: one treated with Quetiapine fumarate (QTP) plus lithium/valproate (LI/VAL) and the other with placebo (PLA) plus LI/VAL. The y-axis represents the percentage of patients with relapse, and the x-axis represents time in weeks.*
FDA Label Image

Figure 2 (E6dd3e1f 31d1 4d58 A717 D0bb4a4b8b6d 03)

Figure 2 (E6dd3e1f 31d1 4d58 A717 D0bb4a4b8b6d 03)
A line graph depicting the proportion of patients with relapse (%) over time in weeks, up to 100 weeks. Two lines are shown: a solid line representing placebo (PLA) plus lithium/valproate (LI/VAL) and a dashed line representing quetiapine fumarate (QTP) plus LI/VAL, illustrating differences in relapse rates between the two groups over the duration of the study.*
FDA Label Image

Label (Lbl713352428)

Label (Lbl713352428)
Label for Quetiapine Tablets USP 100 mg, tablet dosage form. The label states each tablet contains 115.122 mg quetiapine fumarate USP equivalent to 100 mg quetiapine. It includes storage instructions (20° to 25°C), a warning about possible drowsiness, and advises keeping out of reach of children. The product is repackaged by Bryant Ranch Prepack, Inc. and manufactured by Intas Pharmaceuticals Limited. The package contains 100 tablets with NDC 71335-2428-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.